Alnylam Pharmaceuticals
ALNY
#593
Rank
NZ$71.16 B
Marketcap
NZ$533.36
Share price
0.92%
Change (1 day)
34.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company